logo
Sign in

ARKG Stock Price, Chart, Stats & News

Ark Genomic Revolution Ucits ETF AccumUSD
Save

Ark Genomic Revolution Ucits ETF AccumUSD (ARKG) does not currently pay a dividend.

Sector Equity Biotechnology
Category
0.75%
Expense ratio
8.76M
Assets
82.31%
1Y return

ARKG chart

About

The investment objective of the Fund is to generate long term capital growth (5 years or more)

Top 10 ARKG holdings

HoldingOwnership
Health care
8.46%
Health care
8.39%
Health care
6.75%
Health care
5.71%
Health care
5.18%
Health care
4.82%
Health care
4.74%
Health care
4.52%
Health care
4.48%
Health care
4.31%

Similar securities

Based on sector and market capitalization

Report issue